Gastrointestinal and uterine smooth muscle

Gastrointestinal and uterine smooth muscle refers to the involuntary, non-striated muscle tissues located within the walls of the digestive tract and the uterus. These tissues are responsible for critical physiological functions, including the propulsion of luminal contents via peristalsis in the gut and the generation of contractile force during labor and menstruation in the uterus (StatPearls, 2023). Contraction and relaxation in these muscles are primarily regulated by the autonomic nervous system, intracellular calcium levels, and various G protein-coupled receptors (GPCRs) such as muscarinic, adrenergic, and oxytocin receptors (PubMed, PMC4454826). While these tissues are the site of action for many therapeutic agents—such as antispasmodics for gastrointestinal disorders and tocolytics or uterotonics for obstetric care—the term itself describes a physiological system or tissue type rather than a specific, singular molecular target like a receptor or enzyme. Consequently, drug development typically focuses on specific molecular components within these tissues, such as the oxytocin receptor or L-type calcium channels, to achieve therapeutic effects (NIH, 2022).

Other names

GI smooth muscleMyometriumVisceral smooth muscleUterine smooth muscle

Drugs targeting these tissues act by modulating intracellular calcium concentrations, activating or inhibiting G protein-coupled receptors (e.g., muscarinic, oxytocin, or prostaglandin receptors), or blocking voltage-gated calcium channels to alter the frequency and intensity of smooth muscle contractions (PubMed, PMC4454826).